AdvaCAL Calcium Effective Against Bone Loss In Postmenopausal Women

Main Category: Bones / Orthopedics
Also Included In: Menopause;  Women's Health / Gynecology
Article Date: 11 Feb 2010 - 22:00 PDT

email to a friend   printer friendly   opinions  

With Osteoporosis an increasing concern among women of all ages, a recent report in the medical journal Osteoporosis International found that women taking the AAACa (AdvaCAL®) calcium supplements had the highest bone density increase among 32 different calcium studies conducted between 1977 and 2008. The 32 studies involved 3,169 postmenopausal women, 79 skeletal measures and 7 different types of calcium, including dairy.

The report entitled "The Effect of Calcium Supplementation on Bone Loss in 32 Controlled Trials in Postmenopausal Women" was authored by calcium researcher Christopher Nordin, M.D. of Australia. Nordin concluded that calcium intake prevented bone loss in postmenopausal women for at least four years. Results from the 32 studies showed a wide range of bone density changes from taking different types of calcium. Most changes were negative, meaning many women taking calcium still lost bone mass each year. However, AdvaCAL calcium users averaged a 1.5% bone density increase per year, the highest increase among all 79 skeletal measures. Research details are available at http://www.stoposteo.com.

These results dovetail with other published calcium research. A 2007 article in the journal The Lancet showed that AdvaCAL produced the most favorable change to fracture-risk among 17 different calcium studies between 1992 and 2006. The 17 fracture studies involved men and women aged 50+, taking 6 different calciums either alone or with vitamin D.

ABOUT AdvaCAL

AdvaCAL is natural ionic calcium from Japan. Oyster shells are smelted at high temperatures, creating a bioavailable calcium ash. Smelting also removes lead and other impurities. Finally, the calcium is blended with HAI, an amino acid complex from seaweed. HAI has been scientifically shown to boost calcium absorption. Both the calcium and HAI in AdvaCAL have been awarded patents.

"We are pleased but not surprised by AdvaCAL's top ranking in both reports" comments Andrew Lane, president of LaneLabs, the US supplier of AdvaCAL. "The FDA recommends adequate calcium intake with vitamin D, along with physical activity to reduce the risk of osteoporosis in later life. These two reports highlight some differences among calcium supplements. AdvaCAL is a unique Osteoporosis fighter."

Source
LaneLabs

• Additional
• References
• Citations